Trial
NCT02319200
Primary Prevention Hepatocellular Carcinoma by Metformin
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
ANRS, Emerging Infectious Diseases
Condition
Hepatocellular Carcinoma
Intervention
Metformin
Why stopped
Decision of investigator
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-11